Biography

Dr. Lopez did her residency in Pediatrics at the University of Illinois at Chicago, IL,  and her fellowship in Pediatric Endocrinology at Massachusetts General Hospital/Harvard Medical School,  Boston, MA.

She has performed research in the area of type 2 diabetes and obesity in adults and pediatrics  and has participated in several multicenter clinical trials with new drugs for type 2 diabetes.

She is currently the Medical Director for the GENder, Education and Care Interdisciplinary Support (GENECIS) program, which provides mental health and endocrine care for gender non-conforming children and adolescents.

Education

Medical School
Universidad La Salle/Facuitad de Medicina (2000)
Residency
University of Illinois at Chicago (2005), Pediatrics
Fellowship
Massachusetts General Hospital (2008), Pediatric Endocrinology

Specialty Areas

Clinical Interest

  • Diabetes Mellitus Type 1
  • Diabetes Mellitus Type 2
  • Research Interest

    • Gender dysphoria in children and adolescents.
    • Metabolic effects of endocrine therapy in adolescents with gender dysphoria.
    • Obesity in childhood.
    • Type 2 diabetes in pediatrics.

    Publications

    Featured Publications LegendFeatured Publications

    Approach to Children and Adolescents with Gender Dysphoria.
    Lopez X, Stewart S, Jacobson-Dickman E Pediatr Rev 2016 Mar 37 3 89-98
    A role of the Inflammasome in the low storage capacity of the abdominal subcutaneous adipose tissue in obese adolescents.
    Kursawe R, Dixit VD, Scherer PE, Santoro N, Narayan D, Gordillo R, Giannini C, Lopez X, Pierpont B, Nouws J, Shulman GI, Caprio S Diabetes 2015 Dec
    Association of Non-High-Density Lipoprotein Cholesterol with Psychosocial Dysfunction in Children and Adolescents with Obesity.
    Serrano-Gonzalez M, McConnel C, Bokhary M, Oden J, Lopez X Child Obes 2015 Sep
    Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome.
    Warshauer JT, Lopez X, Gordillo R, Hicks J, Holland WL, Anuwe E, Blankfard MB, Scherer PE, Lingvay I Diabetes Metab. Res. Rev. 2015 May
    Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Klein DJ, Battelino T, Chatterjee DJ, Jacobsen LV, Hale PM, Arslanian S Diabetes Technol. Ther. 2014 Oct 16 10 679-87
    Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use.
    Phua EJ, Lopez X, Ramus J, Goldfine AB Diabetes Care 2013 Dec 36 12 e204-5
    Plasma ceramides are elevated in female children and adolescents with type 2 diabetes.
    Lopez X, Goldfine AB, Holland WL, Gordillo R, Scherer PE J. Pediatr. Endocrinol. Metab. 2013 Apr 1-4
    An infant with hypercalcemia and rachitic changes: question.
    Siddique K, Lucke A, Lucio D, Lopez X, Seikaly M Pediatr. Nephrol. 2013 Feb 28 2 245-6, 247-9
    Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans.
    Halperin F, Lopez X, Manning R, Kahn CR, Kulkarni RN, Goldfine AB Diabetes 2012 Feb 61 2 301-9
    Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids.
    Lopez X, Cypess A, Manning R, O'Shea S, Kulkarni RN, Goldfine AB J. Clin. Endocrinol. Metab. 2011 Dec 96 12 3811-21

    Books

    Featured Books Legend Featured Books

    Honors & Awards

    • Graduation with honors from medical school
      (2000)

    Professional Associations/Affiliations

    • American Academy of Pediatrics, Endocrinology Executive Committee Member (2016-2019)
    • Pediatric Endocrine Society, Co-chair of the Transgender and Gender Non-Conforming Youth SIG (2015)
    • World Professional Association for Transgender Health (WPATH) (2014)
    • Diabetes National Medical Advisor, Novo Nordisk, Spain (2008-2010)